Lumos Diagnostics Holdings Limited (LDXHF)
LDXHF Stock Price Chart
Explore Lumos Diagnostics Holdings Limited interactive price chart. Choose custom timeframes to analyze LDXHF price movements and trends.
LDXHF Company Profile
Discover essential business fundamentals and corporate details for Lumos Diagnostics Holdings Limited (LDXHF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
22 Sept 2021
Employees
—
Website
https://lumosdiagnostics.comCEO
Douglas Ward
Description
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
LDXHF Financial Timeline
Browse a chronological timeline of Lumos Diagnostics Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 27 Feb 2025
Earnings released on 31 Oct 2024
Earnings released on 29 Jun 2024
EPS came in at -$0.00 , while revenue for the quarter reached $4.18M .
Earnings released on 31 Mar 2024
EPS came in at -$0.00 , while revenue for the quarter reached $4.18M .
Earnings released on 30 Dec 2023
EPS came in at -$0.01 , while revenue for the quarter reached $2.89M .
Earnings released on 30 Sept 2023
EPS came in at -$0.01 , while revenue for the quarter reached $1.38M .
Earnings released on 29 Jun 2023
EPS came in at -$0.01 , while revenue for the quarter reached $5.37M .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 surpassing the estimated -$0.05 by +90.48%, while revenue for the quarter reached $2.72M , missing expectations by -64.74%.
Earnings released on 31 Dec 2022
EPS came in at -$0.02 , while revenue for the quarter reached $2.54M .
Earnings released on 30 Sept 2022
EPS came in at -$0.02 surpassing the estimated -$0.05 by +67.38%, while revenue for the quarter reached $2.54M , missing expectations by -21.50%.
Earnings released on 26 Aug 2022
Stock split effective on 11 Jul 2022
Shares were split 1077 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Jun 2022
EPS came in at -$0.22 , while revenue for the quarter reached $6.17M .
Earnings released on 27 Feb 2022
EPS came in at -$0.06 falling short of the estimated -$0.03 by -84.92%, while revenue for the quarter reached $5.20M , missing expectations by -34.83%.
Earnings released on 30 Dec 2021
EPS came in at -$0.07 , while revenue for the quarter reached $5.16M .
Earnings released on 29 Aug 2021
EPS came in at -$0.47 falling short of the estimated -$0.05 by -850.07%, while revenue for the quarter reached $10.10M , beating expectations by +5.91%.
Earnings released on 29 Jun 2021
EPS came in at -$0.07 , while revenue for the quarter reached $10.13M .
Earnings released on 30 Dec 2020
EPS came in at -$0.02 , while revenue for the quarter reached $8.92M .
LDXHF Stock Performance
Access detailed LDXHF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.